Brain-signaling research peptide (SFRNGV)

What this is

SFRNGVamide is a six-residue neuropeptide discovered in the cephalochordate Branchiostoma floridae (amphioxus, a small filter-feeding animal that sits near the base of the vertebrate lineage). It is encoded in a neurophysin-containing precursor protein — the same class of carrier protein that packages oxytocin and vasopressin in vertebrates — and belongs to a family called the NG peptides, named for the asparagine-glycine (NG) dipeptide motif they all share. The stored sequence SFRNGV represents the backbone; the active peptide carries a C-terminal amide (-NH₂) that is absent from the raw sequence letters. SFRNGVamide is primarily a research tool for probing the evolutionary origins of neuropeptide signalling systems across animal phyla; it has no known clinical or therapeutic use.

History

SFRNGVamide was identified in 2010 by Elphick, who reported that Branchiostoma floridae encodes a neurophysin-containing precursor that produces two copies of the putative peptide SFRNGVamide (Elphick 2010). The work placed SFRNGVamide within the NG peptide family alongside NGFFFamide from sea urchins (Strongylocentrotus purpuratus) and the NGFWNamide/NGFYNamide peptides from the hemichordate Saccoglossus kowalevskii. Comparative gene structure analysis — showing that an intron falls at the same position (phase 0) in all three genes — provided evidence that the SFRNGVamide precursor gene, the NGFFFamide precursor gene, and the Saccoglossus precursor gene all derive from a common ancestral gene (Elphick 2010). Because precursors of this type were found in ambulacrarians (sea urchins, hemichordates) and in a cephalochordate but not in urochordates or vertebrates, Elphick proposed that the NG peptide gene family dates at least to the common ancestor of the deuterostomes.

What it does

SFRNGVamide's biological function in Branchiostoma has not been experimentally characterised — it remains a predicted neuropeptide based on its precursor structure. Its scientific interest rests largely on a striking sequence coincidence: the N-terminal region of SFRNGVamide is identical to the N-terminal region of neuropeptide S, a mammalian peptide that modulates arousal and anxiety, and it is precisely that shared N-terminal segment that is critical for neuropeptide S biological activity (Elphick 2010). This raised the hypothesis that SFRNGVamide and neuropeptide S may be distant evolutionary relatives — that a common ancestral gene encoding a neurophysin-associated NG peptide gave rise to both lineages, with the neurophysin-encoding portion lost in the vertebrate line that produced neuropeptide S. No receptor-binding studies or physiological assays for SFRNGVamide itself have been reported in the available literature.

Evidence

• Human: No human data. SFRNGVamide is an invertebrate-derived peptide with no known human studies.
• Animal: No functional bioassay data in any animal model reported in the available literature. Identified computationally and by gene structure analysis in Branchiostoma floridae (Elphick 2010).
• In vitro: No binding affinity, receptor activation, or other in vitro measurements reported.